Somatostatin Analogues in the Treatment of Neuroendocrine Tumors: Past, Present and Future

In recent decades, the incidence of neuroendocrine tumors (NETs) has steadily increased. Due to the slow-growing nature of these tumors and the lack of early symptoms, most cases are diagnosed at advanced stages, when curative treatment options are no longer available. Prognosis and survival of pati...

Full description

Bibliographic Details
Main Authors: Anna Kathrin Stueven, Antonin Kayser, Christoph Wetz, Holger Amthauer, Alexander Wree, Frank Tacke, Bertram Wiedenmann, Christoph Roderburg, Henning Jann
Format: Article
Language:English
Published: MDPI AG 2019-06-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/20/12/3049